Logo image of ZENA

ZENATECH INC (ZENA) Stock Fundamental Analysis

NASDAQ:ZENA - Nasdaq - CA98936T2083 - Common Stock - Currency: USD

2.43  +0.13 (+5.65%)

After market: 2.429 0 (-0.04%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ZENA. ZENA was compared to 283 industry peers in the Software industry. While ZENA seems to be doing ok healthwise, there are quite some concerns on its profitability. ZENA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ZENA had negative earnings in the past year.
In the past year ZENA has reported a negative cash flow from operations.
ZENA Yearly Net Income VS EBIT VS OCF VS FCFZENA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -12.94%, ZENA is not doing good in the industry: 64.31% of the companies in the same industry are doing better.
ZENA's Return On Equity of -20.54% is in line compared to the rest of the industry. ZENA outperforms 43.11% of its industry peers.
Industry RankSector Rank
ROA -12.94%
ROE -20.54%
ROIC N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZENA Yearly ROA, ROE, ROICZENA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

ZENA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZENA Yearly Profit, Operating, Gross MarginsZENA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

5

2. Health

2.1 Basic Checks

ZENA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZENA has more shares outstanding
The debt/assets ratio for ZENA has been reduced compared to a year ago.
ZENA Yearly Shares OutstandingZENA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
ZENA Yearly Total Debt VS Total AssetsZENA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 3.38 indicates that ZENA is not in any danger for bankruptcy at the moment.
ZENA has a better Altman-Z score (3.38) than 61.13% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that ZENA is not too dependend on debt financing.
ZENA has a worse Debt to Equity ratio (0.46) than 63.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 3.38
ROIC/WACCN/A
WACC9.54%
ZENA Yearly LT Debt VS Equity VS FCFZENA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 2.17 indicates that ZENA has no problem at all paying its short term obligations.
ZENA's Current ratio of 2.17 is fine compared to the rest of the industry. ZENA outperforms 65.02% of its industry peers.
ZENA has a Quick Ratio of 2.17. This indicates that ZENA is financially healthy and has no problem in meeting its short term obligations.
ZENA's Quick ratio of 2.17 is fine compared to the rest of the industry. ZENA outperforms 65.72% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 2.17
ZENA Yearly Current Assets VS Current LiabilitesZENA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

ZENA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1175.00%.
The Revenue has been growing slightly by 7.44% in the past year.
ZENA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.94% yearly.
EPS 1Y (TTM)-1175%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-543.4%
Revenue 1Y (TTM)7.44%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%-4.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZENA Yearly Revenue VS EstimatesZENA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZENA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZENA Price Earnings VS Forward Price EarningsZENA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZENA Per share dataZENA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZENA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENATECH INC

NASDAQ:ZENA (5/22/2025, 6:41:12 PM)

After market: 2.429 0 (-0.04%)

2.43

+0.13 (+5.65%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.06%
Inst Owner Change-53.92%
Ins Owners32.6%
Ins Owner ChangeN/A
Market Cap61.97M
AnalystsN/A
Price TargetN/A
Short Float %13.44%
Short Ratio0.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 43.82
P/FCF N/A
P/OCF N/A
P/B 3.94
P/tB 7.03
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.06
BVpS0.62
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.94%
ROE -20.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 514.16%
Cap/Sales 73.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 2.17
Altman-Z 3.38
F-Score1
WACC9.54%
ROIC/WACCN/A
Cap/Depr(3y)356.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)44.44%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1175%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-543.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.44%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%-4.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1375.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-337.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-398.17%
OCF growth 3YN/A
OCF growth 5YN/A